كل ما تود معرفته عن BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier/File Photo

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through…

26 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

US Republican presidential hopeful Donald Trump speaks during the American Israel Public Affairs Committee (AIPAC) 2016 Policy Conference at the Verizon Centre in Washington, DC, on 21 March 2016.

SAUL LOEB / AFP

Politics

The Israel lobby’s responsibility for the Iran war

17 March 2026

Advocates for the US-Israeli special relationship have played a special role

Stephen M. Walt

Lina Jaradat

Business & Economy

Strait of Hormuz: the waterway critical to global trade

18 March 2026

Any disruption in the Hormuz has cascading knock-on effects that extend far beyond energy markets, impacting international trade. Al Majalla explores all this and more.

Al Majalla - London

AFP/ Al Majalla

Politics

Iran after Larijani: a war without an exit

18 March 2026

Israel's assassination of the pragmatic and highly influential National Security Chief closes the path to de-escalation

Futoshi Matsumoto

Pete Reynolds

Business & Economy

Energy infrastructure attacks and the new security imperative

17 March 2026

By attacking Gulf energy infrastructure, Iran aims to apply economic and geopolitical pressure as a way to avoid large-scale conflict

Jessica Obeid

US Navy sailors send signals to an E-2D Hawkeye aircraft, 124th Airborne Command and Control Squadron, as it walks on the deck of the aircraft carrier USS Gerald R. Ford, on 28 February 2026.

Reuters

Documents & Memoirs

Could the US-Iran war spark World War III?

16 March 2026

The current conflict is unlikely to go global for now, but the speed at which it has spread regionally is alarming. A look at history shows the geopolitical factors that led to world wars.

Christopher Phillips

Sections

Regions

More

LATEST ISSUE

BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

The Israel lobby’s responsibility for the Iran war

Strait of Hormuz: the waterway critical to global trade

Iran after Larijani: a war without an exit

Energy infrastructure attacks and the new security imperative

Could the US-Iran war spark World War III?

OPINIONS

Strait of Hormuz: the waterway critical to global trade

Energy infrastructure attacks and the new security imperative

The US-Iran war confirms China’s four worst fears

Iran after Larijani: a war without an exit

BioNTech

Sign up for the Weekly Newsletter